#United States #Veeva Systems #Biopharma #Pleasanton #Vault CRM

Veeva Vault CRM: A Transformative Solution for Biopharma

Veeva Systems, a prominent name in the life sciences industry, has recently announced a remarkable milestone: over 125 customers across major global biopharmaceutical companies have successfully adopted its Vault CRM platform. This strategic move positions Veeva at the forefront of digital transformation within the biopharma sector.

Since its launch, Vault CRM has been designed specifically for life sciences, integrating comprehensive industry functionalities that align with regulatory compliance and enhance customer engagement. As companies navigate an increasingly complex landscape—ranging from product launches to managing established brands—Vault CRM provides vital support through its versatile capabilities.

Driving Industry Change with Agentic CRM

The momentum behind the adoption of Vault CRM is a testament to its clear business value. Arno Sosna, the president of the CRM Suite at Veeva, highlighted that the platform not only meets but exceeds the needs of commercial and medical teams, allowing them to optimize customer interactions. Sosna stated, "More than 125 customers are already live with Vault CRM and on the fast path to agentic customer engagement," emphasizing Veeva’s commitment to customer success and product quality.

Vault CRM’s suite includes additional applications such as Events Management, Service Center, Campaign Manager, and Patient CRM, providing a holistic approach to customer relationship management in the biopharma industry. This interconnectedness empowers companies to support the entire product lifecycle, from initial market preparation to maximizing the potential of established brands.

The Future of Veeva CRM

Alongside the launch of Vault CRM, Veeva has also made a significant announcement regarding the support timeline for its legacy Veeva CRM. The end-of-support date for Veeva CRM has been pushed from September 2030 to December 2029, ensuring that clients have ample time to transition to the new platform without disruption. This strategic decision underlines Veeva's dedication to providing ongoing support and guidance to its clientele as they transition to more advanced solutions.

A Commitment to Innovation

Innovation remains at the core of Veeva's mission. With the addition of Veeva AI capabilities, Vault CRM further streamlines communications and interactions, enabling users to harness data insights more effectively. By leveraging artificial intelligence, Veeva aims to enhance CRM functionality, paving the way for a future where biopharma companies can engage with customers in unprecedented ways.

As a Public Benefit Corporation, Veeva Systems balances the interests of various stakeholders, ensuring not only the success of their products but also the well-being of customers and employees. This dedication to innovation and stakeholder engagement has solidified Veeva’s position as a leader in the industry.

Conclusion

As more than 125 customers step into the future with Vault CRM, Veeva's vision for an agentic CRM landscape continues to unfold. The company is poised to impact the biopharma industry significantly, driving not just customer success, but also innovation and operational excellence. For more information about Veeva Systems and its transformative solutions in life sciences, visit veeva.com.